Saturday, June 13, 2020 8:22:37 AM
Yes of course. If we meet either or both end points
But reflecting on the last 7 1/2 years for me I have to say
nothing other than off the charts results could make
this friggin nightmare seem worth it.
BSB it really sucks big time. I have learned a few pointers myself too when it comes to biotech.
A. There is not one biotech stock I have seen, perhaps there are in the past but I havent seen one and I have studied dozens, where it was worth investing years and years before TLD. I see zero benefits for retail shareholders to invest in biotech years before TLD. Moreover, I only see risk, years of frustration, and very little chance of success.
B. The most profitable way to invest in a biotech is right after TLD announcement with wonderful results. Yes you might miss a 2x, 3x bagger at opening but hell the 5-7x bagger in the months afterward (due to the PR push) that starts right after you jump in the next day is all worth avoiding the years of frustration.
For example, look at Axesome stock when they released positive TLD on Nov 2 2018. It jumped at the opening the next day from $ 2 to $ 7, ok buy at $ 7 then it went up to $ 100 in the 12 months following that. Big deal the
$ 2 $ 7 miss vs the years of wait, frustration and risk. If one would handle that strategy with NWBO then one would be much more well off then starting years ago.
C. There are many Biotechstocks with great potential don't become a biotech groupie falling in love with the stock because you married the b*ch years ago. I see this over and over, also with NWBO. Don't apologize for supporting the effort to find a cure for this or that disease BS, management will love you for it with their millions in risk-free reward. (LP)
D. Look at great management AND science, not just science.
E. If you want to make money with biotech with a 90% guarantee of success... short them after stock market introduction. They all follow the opposite of the Amazon stock by starting with a pumped high at market introduction then sliding down into penny territory.
F. There are many ways to have an 8x bagger outside biotech look at Nikola Corp (Tessla competitor) started at $ 10 in January 2020 now $ 67
G. If anyone is interested in a real nonfictional EPIC short squeeze look at GameStop $ 4 with their shares being shorted for 105%. Now thats an upcoming short squeeze NWBO fans!
my 2 cents
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
